2020
DOI: 10.1016/j.wneu.2020.03.135
|View full text |Cite
|
Sign up to set email alerts
|

Shunt Treatment for Coccidioidomycosis-Related Hydrocephalus: A Single-Center Series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…Additionally, and in accordance with experience from other centres, 60% of the patient that had a ventriculoperitoneal shunt placed required a revision. 28,29 Disease surveillance in our state is encouraged to better understand the geographic distribution, impact and disease risk.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, and in accordance with experience from other centres, 60% of the patient that had a ventriculoperitoneal shunt placed required a revision. 28,29 Disease surveillance in our state is encouraged to better understand the geographic distribution, impact and disease risk.…”
Section: Discussionmentioning
confidence: 99%
“…9,10 The experts also agreed that shunt placement should not be delayed with concern that delays in shunting lead to worse patient outcomes. 8,11 However, published guidelines do not specify optimal timing for a shunt in the management of hydrocephalus with increased ICP for minimally symptomatic patients. Some studies question the necessity of shunt placement early in the disease process due to risks and complications associated with indwelling shunts.…”
Section: Discussionmentioning
confidence: 99%
“… 9 , 10 The experts also agreed that shunt placement should not be delayed with concern that delays in shunting lead to worse patient outcomes. 8 , 11 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients who underwent VP shunt placement for hydrocephalus required revision surgery, often multiple times (52%), likely contributing to the rehospitalization rates. While high rates of medication nonadherence was noted and may have contributed to shunt failures, previous studies in patients with CM have shown high rates of shunt failure even with adequate medical management [ 7 , 16 , 23 , 24 ]. Twenty-three percent of the patients died due to complications from CM, and we found that encephalopathy at presentation was associated with a significantly higher risk of death.…”
Section: Discussionmentioning
confidence: 99%